Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

Taking Dutasteride with Ketoconazole can increase Dutasteride's effects and side effects.

The method accurately and quickly measures silodosin and dutasteride in mixtures.

Oral finasteride and dutasteride may negatively affect erectile function in rats.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

A fast and accurate method was developed to measure alfuzosin and dutasteride in human plasma.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The combination of finasteride, dutasteride, and minoxidil is generally safe for treating male hair loss with minimal side effects.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Finasteride safely lowers DHT levels without affecting testosterone.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.

Finasteride causes fewer sexual side effects than dutasteride in men with BPH.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

5alpha-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT, offering symptom relief and potential future uses.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Chronic use of 1 mg/day finasteride for hair loss may delay prostate cancer diagnosis by lowering PSA levels.